Alnylam Pharmaceuticals Inc

More

• Alnylam takes smaller 1Q loss on lower costs Monday, 6 May 2013 | 6:07 PM ET

  CAMBRIDGE, Mass.-- Alnylam Pharmaceuticals Inc. said Monday it took a smaller loss in the first quarter as its expenses decreased. Alnylam lost $9 million, or 15 cents per share, in the latest quarter. A year ago the company took a loss of $11.4 million, or 25 cents per share.

• Cramer Highlights Biotech 'Game Changers' Wednesday, 3 Apr 2013 | 7:10 PM ET

  

  "Drug stocks can rally in any environment," Cramer said, highlighting three companies in particular.

• Lightning Round: Vonage, Bank of America, Molycorp and More Friday, 22 Feb 2013 | 7:27 PM ET

  

  The "Mad Money" host comments on viewers' favorite stocks!